Tweets
Patients with type 2 SLE present with fatigue, pain, brain fog and mood changes.
Type 1 & 2 often coexist but type 2 SLE impacts QOL.
@RheumNow #lupus #APLAR2026 https://t.co/aMtoIprPWG
sheila @RHEUMarampa ( View Tweet )
4 hours 31 minutes ago
Excites to report on #APLAR26 in Seoul, S. Korea for @RheumNow along with Drs. @RHEUMarampa and Peter Nash https://t.co/QImSxM7Izi
Jiha Lee @JihaRheum ( View Tweet )
4 hours 32 minutes ago
24-Week Interim Findings from a Randomized Phase 2 Study of Iptacopan (LNP023) Indicate High Remission Rates in Participants with Active ANCA-Associated Vasculitis https://t.co/cUNMo2ngeE and liver safety over time is?
Peter Nash @drpnash ( View Tweet )
4 hours 34 minutes ago
CDR209: A Novel TRBV9×CD3 T Cell Engager for Precision Depletion of Disease-Associated T Cells in Axial Spondyloarthritis https://t.co/RPD7FkgEdQ anti-TRVB and anti-TRAV for your B27 AxSpA patients ( and needs looking at B27 positive PsA ) watch this space
Peter Nash @drpnash ( View Tweet )
4 hours 34 minutes ago
Schett : in vivo the future if it works, during LD aciclovir, co-trimoxazole, CAR-T expansion amount not associated with toxicity, 3 month no vaccination window, all tissues B cell depletion , naive b cells return
APLAR Seoul 2026 #CART #RheumNow
Peter Nash @drpnash ( View Tweet )
4 hours 34 minutes ago
number of naive-like CAR-T infused associates with prolonged survival but highly variable
APLAR Seoul 2026 #CAR-T #Rheum Now
Peter Nash @drpnash ( View Tweet )
4 hours 35 minutes ago
Chan Hong Kong prediction CRS
80/20 - 80% CRS 20% hypoxia hypotension etc predictors 4 groups b cell load and IL6 level
APLAR Seoul 2026 #CART #RheumNow https://t.co/Q3C9RaYPFz
Peter Nash @drpnash ( View Tweet )
4 hours 35 minutes ago
Georg Schett : cure prime goal of therapy! remission off all treatment ,
APLAR Seoul 2026 #CART #RheumNow https://t.co/kygOGdxUSe
Peter Nash @drpnash ( View Tweet )
4 hours 35 minutes ago
lymphodepletion depends on individual cytokine profile and fludarabine PK effects efficacy
APLAR Seoul 2026 #CAR-T #Rheum Now
Peter Nash @drpnash ( View Tweet )
4 hours 37 minutes ago
Raff - Creative - lipid nanoparticle delivery
APLAR Seoul 2026 #CART #RheumNow https://t.co/1O11I5pR8P
Peter Nash @drpnash ( View Tweet )
4 hours 37 minutes ago
“Complex to manage” in SLE not for biologics
APLAR Seoul 2026 Nikpour #SLE #RheumNow https://t.co/4qeRGEVijs
Peter Nash @drpnash ( View Tweet )
4 hours 37 minutes ago
ExVivo advantages
APLAR Seoul 2026 #CART #RheumNow https://t.co/db2jIVDaik
Peter Nash @drpnash ( View Tweet )
4 hours 38 minutes ago
why biologics for “refractory”only - a life on steroids HCO MMF etc?
APLAR Seoul 2026 Nikpour #SLE #RheumNow https://t.co/Fa58nsF5Mk
Peter Nash @drpnash ( View Tweet )
4 hours 38 minutes ago
Prof. Sandra Navarra on GCs in #lupus : “There is NO safe threshold for Prednisone”
Pred use follows a linear risk: As the dose of prednisone increases, damage risk doubles - - - > higher cataract, fracture and CV risks!
@RheumNow #APLAR2026 https://t.co/8GGrwkcd8Q
Links:
sheila @RHEUMarampa ( View Tweet )
4 hours 39 minutes ago
Saag GIOP guidelines
APLAR Seoul 2026 #GIOP #RheumNow https://t.co/HIEHcaQDeO
Peter Nash @drpnash ( View Tweet )
4 hours 39 minutes ago
